Meag Munich Ergo’s DaVita DVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.64M | Sell |
25,579
-23,794
| -48% | -$3.37M | 0.1% | 105 |
|
|
2025
Q1 | $7.55M | Buy |
49,373
+18,410
| +59% | +$2.89M | 0.22% | 77 |
|
|
2024
Q4 | $4.64M | Hold |
30,963
| – | – | 0.15% | 82 |
|
|
2024
Q3 | $5.08M | Sell |
30,963
-1,899
| -6% | -$281K | 0.16% | 85 |
|
|
2024
Q2 | $4.55M | Sell |
32,862
-6,344
| -16% | -$874K | 0.15% | 88 |
|
|
2024
Q1 | $5.41M | Sell |
39,206
-3,149
| -7% | -$378K | 0.2% | 82 |
|
|
2023
Q4 | $4.44M | Sell |
42,355
-27,559
| -39% | -$2.55M | 0.17% | 86 |
|
|
2023
Q3 | $6.61M | Sell |
69,914
-8,306
| -11% | -$847K | 0.29% | 75 |
|
|
2023
Q2 | $7.86M | Sell |
78,220
-3,186
| -4% | -$296K | 0.34% | 73 |
|
|
2023
Q1 | $6.6M | Buy |
81,406
+26,749
| +49% | +$2.14M | 0.31% | 75 |
|
|
2022
Q4 | $4.08M | Buy |
54,657
+5,210
| +11% | +$405K | 0.22% | 77 |
|
|
2022
Q3 | $4.09M | Sell |
49,447
-19
| -0% | -$1.67K | 0.25% | 69 |
|
|
2022
Q2 | $3.96M | Buy |
49,466
+2,791
| +6% | +$282K | 0.24% | 72 |
|
|
2022
Q1 | $5.34M | Sell |
46,675
-16,169
| -26% | -$1.82M | 0.39% | 54 |
|
|
2021
Q4 | $7.14M | Buy |
62,844
+21,420
| +52% | +$2.3M | 0.51% | 48 |
|
|
2021
Q3 | $4.82M | Buy |
41,424
+20,513
| +98% | +$2.57M | 0.84% | 42 |
|
|
2021
Q2 | $2.52M | Buy |
20,911
+10,066
| +93% | +$1.19M | 0.24% | 105 |
|
|
2021
Q1 | $1.17M | Sell |
10,845
-15,850
| -59% | -$1.76M | 0.12% | 160 |
|
|
2020
Q4 | $3.08M | Buy |
26,695
+1,474
| +6% | +$150K | 0.71% | 39 |
|
|
2020
Q3 | $2.16M | Buy |
25,221
+14,922
| +145% | +$1.27M | 0.4% | 67 |
|
|
2020
Q2 | $815K | Buy |
+10,299
| New | +$804K | 0.15% | 134 |
|
|
2020
Q1 | – | Sell |
-1,613
| Closed | -$119K | – | 292 |
|
|
2019
Q4 | $119K | Sell |
1,613
-6,470
| -80% | -$429K | 0.01% | 484 |
|
|
2019
Q3 | $453K | Buy |
8,083
+3,826
| +90% | +$222K | 0.02% | 482 |
|
|
2019
Q2 | $236K | Hold |
4,257
| – | – | 0.02% | 500 |
|
|
2019
Q1 | $228K | Buy |
+4,257
| New | +$236K | 0.02% | 505 |
|
|
2018
Q1 | – | Sell |
-7,325
| Closed | -$533K | – | 422 |
|
|
2017
Q4 | $533K | Sell |
7,325
-34,421
| -82% | -$2.12M | 0.02% | 451 |
|
|
2017
Q3 | $2.45M | Buy |
41,746
+39,746
| +1,987% | +$2.39M | 0.1% | 212 |
|
|
2017
Q2 | $128K | Sell |
2,000
-34,948
| -95% | -$2.31M | 0.01% | 280 |
|
|
2017
Q1 | $2.52M | Sell |
36,948
-18,605
| -33% | -$1.23M | 0.1% | 219 |
|
|
2016
Q4 | $3.6M | Buy |
55,553
+53,553
| +2,678% | +$3.34M | 0.17% | 158 |
|
|
2016
Q3 | $131K | Sell |
2,000
-48,923
| -96% | -$3.44M | 0.01% | 252 |
|
|
2016
Q2 | $3.92M | Buy |
+50,923
| New | +$3.85M | 0.36% | 82 |
|
|
2015
Q2 | – | Sell |
-43,905
| Closed | -$3.59M | – | 207 |
|
|
2015
Q1 | $3.59M | Buy |
+43,905
| New | +$3.37M | 0.17% | 136 |
|
Other funds holding DVA
GCM
Meag Munich Ergo's DVA Position: Q2 2025 in Review
Meag Munich Ergo reduced its DaVita (DVA) stake by 48% in Q2 2025, selling an estimated $3.37M and leaving 25,579 shares worth $3.64M. The position accounts for 0.1% of the portfolio, ranked #105.
Meag Munich Ergo first reported a position in DVA in Q1 2015 and has held it in 33 quarters since. The position peaked at $7.86M in Q2 2023. 592 funds tracked by Wall St. Rank hold DVA as of Q2 2025.
- Meag Munich Ergo held 25,579 shares of DaVita worth $3.64M as of Q2 2025.
- Meag Munich Ergo sold 23,794 DaVita shares in Q2 2025, an estimated $3.37M.
- DaVita made up 0.1% of Meag Munich Ergo's portfolio in Q2 2025, its #105 holding.
- Meag Munich Ergo first reported a position in DaVita in Q1 2015 and has held it in 33 quarters since.
- Meag Munich Ergo's DaVita position peaked at $7.86M in Q2 2023.
- 592 funds tracked by Wall St. Rank held DaVita as of Q2 2025.
Based on Meag Munich Ergo's 13F filing for Q2 2025, filed 16 Jul 2025.